Your CDMO for the next generation of breakthrough medicines

At Center for Breakthrough Medicines, our mission is to save lives by accelerating the development and manufacturing of advanced therapies.

Our fully integrated services include drug substance and drug product for all phases of the product lifecycle at a single site.

Speak With An Expert

Explore our capabilities

Committed to saving lives together

The Center for Breakthrough Medicines (CBM) is uniquely positioned with the world’s largest single-site advanced therapies facility, located in the birthplace of cell and gene therapy and staffed by the most experienced depth of scientific talent in the industry.

Learn about our vision

20+ Viral Vector Suites

20+ Cell Processing Suites

200 L GMP Plasmid Manufacturing

180+ Analytical Assays

Breakthrough ideas and recent events

Center for Breakthrough Medicines and jCyte Announce Strategic Partnership to Manufacture jCyte’s Innovative Cell Therapy for Treatment of Retinal Degenerative Diseases.

September 20, 2022

CBM has appointed of Mandy Conver as Senior Vice President (SVP) of Business Development for Testing & Analytics, and Jennifer Manning as (SVP) of Global Strategic Partnerships.

July 27, 2022

The Center for Breakthrough Medicines (CBM) in partnership with the Discovery Labs announced today the acceleration of plans to build capacity to manufacture more than 10,000 patient therapies in direct response to the critical shortage of cell therapy supply, which will help patients win their courageous battles against cancer.

June 13, 2022

iECURE, a gene editing company focused on mutation-agnostic in vivo gene insertion, or knock-in, editing for the treatment of liver disorders with significant unmet need, and Center for Breakthrough Medicines (CBM) today announced the companies have entered into a strategic collaboration wherein CBM will produce and supply Good Manufacturing Practices (GMP)-grade adeno-associated virus (AAV) for use in iECURE’s future clinical studies to enable development of iECURE’s programs.

May 25, 2022

Strategic Partnership to Deliver US Based Manufacturing Capacity for Novel Cell Therapy King of Prussia

April 12, 2022

Testing Business Unit Will Grow to More Than 400 Employees, Eliminate Wait Times, and Enable Faster Release Times…

February 16, 2022

read all press here

Join us in creating breakthrough therapies

CBM offers scientists the opportunity to work at the cutting edge of cell and gene therapy, developing breakthrough treatments.

You will work amongst the most experienced and talented people in the industry, including true pioneers of advanced therapies.

We are on a mission to be the world’s leading advanced therapy partner, and we want you to be part of our growth and success.

With a culture of empowerment and innovation, we will support you in creating new therapies that transform patients’ lives.

Life at CBM

Our empowering culture supports people committed to transforming patients’ lives.

Learn More >

Top-Tier Peers

CBM is led by an amazing team. Discover the caliber of people you will work with.

Learn more >

make your breakthrough >

1 / 4

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.